Building an evidence base on hospital-acquired COVID & patient safety failures, to secure proper investigation, accountability & learning - starting in Wales.
Feb 4 • 7 tweets • 1 min read
🧵 THREAD: The quiet revolution in aerosol transmission (2017–2019)
In the years just before COVID, scientists were increasingly clear that “droplet vs airborne” was a false binary and that real-world transmission didn’t fit it.
Across epidemiology, virology, and aerosol science, researchers were synthesising evidence from influenza, SARS-1, measles, and TB that challenged droplet-based infection models.
Feb 2 • 7 tweets • 2 min read
🧵What infection control failed to integrate
Outside formal IPC guidance, between 2013-2016 scientists were uncovering how everyday human activity generates infectious aerosols in indoor spaces, a finding with direct consequences for hospital transmission.
Using high-speed imaging, Lydia Bourouiba (MIT fluid dynamics) and colleagues showed that coughs, sneezes and speech produce turbulent gas clouds that generate fine aerosols capable of remaining suspended in shared air.
(JAMA 2014; NEJM 2016)
Jan 19 • 8 tweets • 1 min read
Aerosol transmission of SARS-CoV-1 was identified during the 2002–2003 SARS outbreak, including in hospital settings
This was recognised during the outbreak itself, not years later, when transmission patterns could not be explained by droplets or close contact alone.
Jan 16 • 6 tweets • 1 min read
How do aerosol viruses like SARS-CoV-2 spread in hospital settings? 🧵
Understanding airborne transmission is essential to preventing hospital-acquired COVID.
Aerosols are tiny particles released when people breathe, speak, cough, or shout.
Unlike droplets, aerosols can remain suspended in the air, travel beyond close contact, and accumulate indoors.